Delivery Order SPE2DB22D2007-SPE2DB25FJ0ZY

Award Date 4/25/25
Potential Completion Date 4/28/25
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB20D3303|SPE2DB25FZ2Z8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is valued at $3,094.22 and has an ultimate completion date of March 13, 2025. The contract is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product, and does not have a...
This federal contract award, SPE2DB22D3011|SPE2DB25FP9KM, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,947.88 firm fixed-price delivery order is for EMVERM 100 MG TABLET CHEW UDS medical supplies, with a completion date of February 21, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,462.31, is a Firm Fixed Price Delivery Order for the supply of EMVERM 100 MG TABLET CHEW, a medication. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a medication, with a ceiling value of $5,746.84 and a period of performance through October 8, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $9,762.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The DO covers the supply of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product, with a performance period...
This federal contract award, with ID SPE2DB22D1002|SPE2DB25FKVV7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,199.49 fixed-price delivery order is for 4566769164 - EMVERM 100 MG TABLET CHEW UDS, with a completion date of December 20, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and does not have any major subcontractors listed. The contract is...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $19,013.28 firm fixed price contract is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract has an ultimate completion date of September 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of EMVERM 100 MG TABLET CHEW medical supplies. The contract, valued at $24,685.31, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of March 19, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside. Amerisourcebergen...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of the pharmaceutical product EMVERM 100 MG TABLET CHEW UDS. The contract, valued at $20,879.81, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA). The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,872.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of EMVERM 100 MG TABLET CHEW UDS. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of October 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to supply the specified pharmaceutical product to support military treatment facilities and federal...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ0ZY
    Delivery Order

This federal contract award, with ID SPE2DB22D2007|SPE2DB25FJ0ZY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,213.77 firm fixed-price delivery order is for the supply of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product.

The contract has an ultimate completion date of April 28, 2025 and was awarded on April 25, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/25/25, 11:22 AM